A phase 1 clinical trial utilizing human bone marrow CD34+ stem cells for patients with retinal vascular occlusion, hereditary or non-exudative age-related macular degeneration (AMD), or retinitis pigmentosa (RP) has shown safety and feasibility. Read more…
New treatment potential for babies with Retinopathy of Prematurity
A gene known to play a major role in constricting blood vessels also appears to be a major player in the aberrant blood vessel growth that can destroy the vision of premature babies such as in Retinopathy of Prematurity and possibly in Diabetic Retinopathy. Read more…
Rosemary may have a beneficial effect for patients with Age-related macular degeneration and Retinitis Pigmentosa
Scientists at the Del E Web Center for Neuroscience, Aging, and Stem Cell Research, Sanford-Burnham Medical Research Institute, La Jolla, California, have found that carnosic acid (CA), present in rosemary extract, may potentially have clinical application to diseases affecting the outer retina, including age-related macular degeneration (AMD) and retinitis pigmentosa (RP). Read more…